This year's edition of our annual Notable Articles collection, selected by NEJM editors, showcases the most significant contributions to clinical medicine and patient care. Inside, you will find article abstracts, accompanying Editorials, and Plain Language Summaries from the selected studies, plus a letter from Eric J. Rubin, M.D., Ph.D., Editor-in-Chief. Download your free copy of this exclusive collection today!
Featured studies include:
- Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma
- Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
- Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
- Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
- Bonus notable articles from NEJM Evidence, NEJM AI, and NEJM Catalyst Innovations in Care Delivery
- And more!
We hope that you enjoy this year in review of medical research from the
New England Journal of Medicine.
This trial demonstrates a highly effective new therapy that prevents HIV acquisition in women. The challenge now is scalability to those at risk.
– Dr. Lindsey Baden, Deputy Editor, NEJM, on Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women